Similar effects were also observed in a mouse model of metastatic triple-negative breast cancer (an aggressive, hormone-insensitive carcinoma [225]) treated with heterodimeric IL-15, which lowered the number of tumor cells in the blood and initiated a decline in tumor colonization of the lungs [226]. This evidence concerns the gene IL15 and neoplasm.